AVEO Pharmaceuticals

Patent cliffs & loss of exclusivity

Company

Company

Official Websitehttp://www.aveooncology.com/

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. FOTIVDATIVOZANIB HYDROCHLORIDESmall mol.Nov 2039
  2. FOTIVDATIVOZANIB HYDROCHLORIDESmall mol.Nov 2039

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.